EXOZ insider trading — Exozymes Inc.
Over the last 90 days, insiders at Exozymes Inc. (EXOZ) made 2 open-market purchases worth $6K and 0 open-market sales worth $0, making them net buyers by $6K. The largest purchase was by Heltzen Michael (Chief Executive Officer), who bought 505 shares for $4K on Aug 26, 2026.
Updated Oct 16, 2026.
Recent EXOZ insider transactions
Every Form 4 filed by Exozymes Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Heltzen Michael | Chief Executive Officer | P · Purchase | Direct | 505 | $7.48 | $4K | Form 4 |
| Aug 25, 2026 | Heltzen Michael | Chief Executive Officer | P · Purchase | Direct | 350 | $7.51 | $3K | Form 4 |
| Aug 19, 2026 | Heltzen Michael | Chief Executive Officer | A · Grant/award | Direct | 8,841 | $6.40 | $57K | Form 4 |
| Aug 19, 2026 | Perriman Damien Alan | Chief Commercial Officer | M · Option exercise | Direct | 19,612 | — | — | Form 4 |
| Aug 19, 2026 | Korman Tyler Paz | Chief Scientific Officer | M · Option exercise | Direct | 32,964 | — | — | Form 4 |
EXOZ insider trading FAQ
Are insiders buying EXOZ stock?
Yes. In the last 90 days, Exozymes Inc. insiders made 2 open-market purchases totaling $6K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading EXOZ?
Recent buyers: Heltzen Michael.
Where does EXOZ insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.